DDrare: Database of Drug Development for Rare Diseases

Recombinant human somatotropin (DrugBank: Somatotropin)

2 diseases

ID	Disease name (Link within this page)	Number of trials
78	Hypopituitarism	1
236	Pseudohypoparathyroidism	1

78. Hypopituitarism [ 462 clinical trials, 346 drugs, (DrugBank: 45 drugs), 41 drug target genes, 80 drug target pathways]

Searched query = "Hypopituitarism", "Anterior pituitary hypothyroidism", "Syndrome of abnormal secretion of gonadotropin", "Hyposecretion of gonadotropins", "Adrenocorticotropic hormone deficiency", "ACTH deficiency", "Thyroid-stimulating hormone deficiency", "TSH deficiency", "Growth hormone deficiency", "GH deficiency", "GHD", "CGHD", "AGHD", "Prolactin deficiency", "PRL deficiency"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 462 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00497484 (ClinicalTrials.gov)	February 1995	5/7/2007	Evaluation of rhGH Replacement Therapy in Patients With Pseudohypoparathyroidism Type Ia (PHP Ia)	Evaluation of rhGH Replacement Therapy in Patients With Pseudohypoparathyroidism Type Ia (PHP Ia)	Pseudohypoparathyroidism;Growth Hormone Deficiency, Dwarfism	Drug: recombinant human somatotropin	University of Milan	Eli Lilly and Company	Active, not recruiting	1 Year	18 Years	Both		N/A	Italy

236. Pseudohypoparathyroidism [ 6 clinical trials, 4 drugs, (DrugBank: 2 drugs), 20 drug target genes, 28 drug target pathways]

Searched query = "Pseudohypoparathyroidism", "PHP", "PHP1a", "PHP1b", "PHP1c", "PHP2"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 6 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00497484 (ClinicalTrials.gov)	February 1995	5/7/2007	Evaluation of rhGH Replacement Therapy in Patients With Pseudohypoparathyroidism Type Ia (PHP Ia)	Evaluation of rhGH Replacement Therapy in Patients With Pseudohypoparathyroidism Type Ia (PHP Ia)	Pseudohypoparathyroidism;Growth Hormone Deficiency, Dwarfism	Drug: recombinant human somatotropin	University of Milan	Eli Lilly and Company	Active, not recruiting	1 Year	18 Years	Both		N/A	Italy